Rabelo, Vitor W <br/><br/>
Targeting CYP51 for drug design by the contributions of molecular modeling.  [electronic resource] 

 -  Fundamental & clinical pharmacology  Feb 2017 
 - 37-53 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1472-8206 
<br/><br/><label>Standard No.: </label>10.1111/fcp.12230  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>14-alpha Demethylase Inhibitors--chemistry<br/>Animals<br/>Antifungal Agents--chemistry<br/>Antiprotozoal Agents--chemistry<br/>Binding Sites<br/>Drug Design<br/>Humans<br/>Molecular Docking Simulation<br/>Mycoses--drug therapy<br/>Protein Binding<br/>Protein Structure, Secondary<br/>Protozoan Infections--drug therapy<br/>Sterol 14-Demethylase--biosynthesis<br/>Substrate Specificity